Rodin Therapeutics
VerifiedDevelops novel therapeutics for neurological disorders by applying insights of epigenetics.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$108—162m (Dealroom.co estimates Sep 2017.)
Cambridge Massachusetts (HQ)